Antipsychotics Atypicala | |||
| |||
| Inactive metabolites | ||
| 20 - 80 mg bid | ||
| 7 h | ||
| 10 - 80 mg bid | ||
| |||
| |||
| Dose adjustment not necessary for CrCl 10 - 60 mL/min per manufacturer; some clinicians recommend avoiding in ESRD because of prolonged QT interval and risk of life-threatening arrhythmias that may be higher with electrolyte shift | ||
